野生型IL-7Rα过表达促进T细胞急性淋巴细胞白血病/淋巴瘤
本研究利用四环素诱导的Il7r转基因小鼠和Rosa26 IL7R敲入小鼠,发现野生型IL-7Rα过表达可驱动胸腺细胞自我更新和胸腺增生,进而浸润淋巴结、脾和骨髓,最终导致致死性白血病。肿瘤模拟人类T-ALL特征,且已建立的肿瘤在二次移植后可能不再依赖高水平IL-7R表达,但仍对IL-7R信号通路抑制剂敏感。
要点
- 野生型IL-7Rα过表达足以促进T细胞肿瘤发生,不依赖突变激活。
- 肿瘤呈现PI3K/Akt通路过度激活及JAK/STAT、Notch信号激活特征。
- 已建立肿瘤对ruxolitinib、AZD1208、dactolisib、palbociclib和venetoclax敏感。
核心结论
- 野生型IL-7Rα高表达可促进T细胞肿瘤发生,即使没有IL-7Rα突变激活。
研究设计与样本
- 使用四环素诱导的Il7r转基因小鼠和Rosa26 IL7R敲入小鼠模型。
主要发现
- 过表达IL-7Rα驱动胸腺细胞潜在自我更新和T细胞前体增殖相关的胸腺增生。
- 肿瘤浸润淋巴结、脾和骨髓,最终导致致死性白血病。
- 肿瘤模拟人类T-ALL特征,包括免疫表型和遗传亚型异质性。
- 肿瘤频繁出现PI3K/Akt通路过度激活,伴p27Kip1下调和Bcl-2上调。
- 基因表达特征显示JAK/STAT、PI3K/Akt/mTOR和Notch信号激活。
临床怎么用
- 高野生型IL7R表达的T-ALL患者可能从IL-7R信号通路抑制剂中获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tight regulation of IL-7Rα expression is essential for normal T-cell development. IL-7Rα gain-of-function mutations are known drivers of T-cell acute lymphoblastic leukemia (T-ALL). Although a subset of patients with T-ALL display high IL7R messenger RNA levels and cases with IL7R gains have been reported, the impact of IL-7Rα overexpression, rather than mutational activation, during leukemogenesis remains unclear. In this study, overexpressed IL-7Rα in tetracycline-inducible Il7r transgenic and Rosa26 IL7R knockin mice drove potential thymocyte self-renewal, and thymus hyperplasia related to increased proliferation of T-cell precursors, which subsequently infiltrated lymph nodes, spleen, and bone marrow, ultimately leading to fatal leukemia. The tumors mimicked key features of human T-ALL, including heterogeneity in immunophenotype and genetic subtype between cases, frequent hyperactivation of the PI3K/Akt pathway paralleled by downregulation of p27Kip1 and upregulation of Bcl-2, and gene expression signatures evidencing activation of JAK/STAT, PI3K/Akt/mTOR and Notch signaling. Notably, we also found that established tumors may no longer require high levels of IL-7R expression upon secondary transplantation and progressed in the absence of IL-7, but remain sensitive to inhibitors of IL-7R-mediated signaling ruxolitinib (Jak1), AZD1208 (Pim), dactolisib (PI3K/mTOR), palbociclib (Cdk4/6), and venetoclax (Bcl-2). The relevance of these findings for human disease are highlighted by the fact that samples from patients with T-ALL with high wild-type IL7R expression display a transcriptional signature resembling that of IL-7-stimulated pro-T cells and, critically, of IL7R-mutant cases of T-ALL. Overall, our study demonstrates that high expression of IL-7Rα can promote T-cell tumorigenesis, even in the absence of IL-7Rα mutational activation.
引用
- Silva A, Almeida ARM, Cachucho A, et al. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma. Blood. 2021. PMID: 33970999. doi:10.1182/blood.2019000553
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。